Linfong Tzeng represents public and private companies in the life sciences, biotech, and technology industries on complex intellectual property litigation before federal courts, the Patent Trial and Appeal Board (PTAB), and the US International Trade Commission.
Linfong leverages his scientific analytical and research skills to help clients navigate complex pharmaceutical and technology patent disputes, as well as high-stakes intellectual property matters.
Prior to joining Latham, Linfong worked for BioLegend, a biomedical research tool development company, where he analyzed biotechnology patents to advise business development.
Before that, Linfong was a research and teaching assistant at the University of California, Davis, where he researched the relationship between DNA replication and initiation of sporulation in the bacterium Myxococcus xanthus and taught advanced microbiology lab, microbial physiology, and biochemistry lab sections.
Linfong has published articles in leading science and technology publications.